173 related articles for article (PubMed ID: 37731522)
1. Clinical benefits of oral anticoagulants in atrial fibrillation patients with dementia: a systematic review and meta-analysis.
Wang D; Xu X; Han X; Xie J; Zhou H; Peng W; Pan G
Front Cardiovasc Med; 2023; 10():1265331. PubMed ID: 37731522
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
3. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis.
Su X; Yan B; Wang L; Lv J; Cheng H; Chen Y
Am J Kidney Dis; 2021 Nov; 78(5):678-689.e1. PubMed ID: 33872690
[TBL] [Abstract][Full Text] [Related]
4. The effect of oral anticoagulants on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis.
Latif F; Nasir MM; Meer KK; Farhan SH; Cheema HA; Khan AB; Umer M; Rehman WU; Ahmad A; Khan MA; Almas T; Mactaggart S; Nashwan AJ; Ahmed R; Dani SS
Int J Cardiol Cardiovasc Risk Prev; 2024 Jun; 21():200282. PubMed ID: 38766665
[TBL] [Abstract][Full Text] [Related]
5. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
[TBL] [Abstract][Full Text] [Related]
6. Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study.
Mongkhon P; Fanning L; Lau WCY; Tse G; Lau KK; Wei L; Kongkaew C; Wong ICK
Heart Rhythm; 2020 May; 17(5 Pt A):706-713. PubMed ID: 31931172
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Non-vitamin K antagonist oral anticoagulants with amiodarone, P-glycoprotein inhibitors, or polypharmacy in patients with atrial fibrillation: Systematic review and meta-analysis.
Kim IS; Kim HJ; Yu HT; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
J Cardiol; 2019 Jun; 73(6):515-521. PubMed ID: 30770140
[TBL] [Abstract][Full Text] [Related]
9. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis.
Harrison SL; Buckley BJR; Ritchie LA; Proietti R; Underhill P; Lane DA; Lip GYH
J Am Geriatr Soc; 2022 Aug; 70(8):2386-2392. PubMed ID: 35587227
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of oral anticoagulant discontinuation in atrial fibrillation: a systematic review and meta-analysis.
Kefale AT; Bezabhe WM; Peterson GM
Expert Rev Clin Pharmacol; 2023; 16(7):677-684. PubMed ID: 37309076
[TBL] [Abstract][Full Text] [Related]
12. Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis.
Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
J Cardiol; 2018 Aug; 72(2):105-112. PubMed ID: 29519547
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies.
Franchin L; Piroli F; Demola P; Mantovani F; Iannaccone M; Manfredi R; D'Ascenzo F; Fortuni F; Ugo F; Meucci F; Navazio A; Boccuzzi G
Front Cardiovasc Med; 2023; 10():1212161. PubMed ID: 37829693
[TBL] [Abstract][Full Text] [Related]
14. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Wang Y; Li L; Wei Z; Lu S; Liu W; Zhang J; Feng J; Wang D
Medicines (Basel); 2023 Jan; 10(1):. PubMed ID: 36662497
[TBL] [Abstract][Full Text] [Related]
16. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
[TBL] [Abstract][Full Text] [Related]
19. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
